Wall Street is projecting that earnings and revenue will rise year-over-year.
Analysts surveyed by FactSet are looking for earnings of $3.00 per share on revenue of $13.41 billion.
During the same period a year ago, the Louisville, KY-based health insurer earned $2.16 per share on revenue of $13.36 billion.
Separately, TheStreet Ratings Team has a "Buy" rating with a score of B+ on the stock.
The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations.
The team believes its strengths outweigh the fact that the company has had sub par growth in net income.
Recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.
You can view the full analysis from the report here: HUM